Near-infrared fluorescent imaging of tumor apoptosis

Cancer Research

Volumn 63, Issue 8, 2003, Pages 1936-1942

  Petrovsky, Alexander ^a   Schellenberger, Eyk ^a   Josephson, Lee ^a   Weissleder, Ralph ^a   Bogdanov Jr , Alexei ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CYCLOPHOSPHAMIDE; GREEN FLUORESCENT PROTEIN; LIPOCORTIN 5; PROTEIN; PROTEIN DSRED2; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE; GENETIC TRANSFECTION; GLIOSARCOMA; HUMAN; HUMAN CELL; IMAGING SYSTEM; LEUKEMIA CELL LINE; LEWIS CARCINOMA; MOUSE; NEAR INFRARED FLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR CELL;

ANIMALS; ANNEXIN A5; APOPTOSIS; CARBOCYANINES; CARCINOMA, LEWIS LUNG; CYCLOPHOSPHAMIDE; FEMALE; FLUORESCENT DYES; GLIOSARCOMA; GREEN FLUORESCENT PROTEINS; HUMANS; JURKAT CELLS; LUMINESCENT PROTEINS; MICE; MICE, NUDE; RATS; SPECTROSCOPY, NEAR-INFRARED; TRANSFECTION;

EID: 0037447317     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Kerr, J. F., Wyllie, A. H., and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
2. Chinnaiyan, A. M., Prasad, U., Shankar, S., Hamstra, D. A., Shanaiah, M., Chenevert, T. L., Ross, B. D., and Rehemtulla, A. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc. Natl. Acad. Sci. USA, 97: 1754-1759, 2000.
3. Blankenberg, F. G., Storrs, R. W., Naumovski, L., Goralski, T., and Spielman, D. Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy. Blood, 87: 1951-1956, 1996.
4. Blankenberg, F. G., Katsikis, P. D., Storrs, R. W., Beaulieu, C., Spielman, D., Chen, J. Y., Naumovski, L., and Tait, J. F. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood, 89: 3778-3786, 1997.
5. Aboagye, E. O., Bhujwalla, Z. M., Shungu, D. C., and Glickson, J. D. Detection of tumor response to chemotherapy by IH nuclear magnetic resonance spectroscopy: effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma 1 tumors. Cancer Res., 58: 1063-1067, 1998.
6. Kline, R. P., Wu, E. X., Petrylak, D. P., Szabolcs, M., Alderson, P. O., Weisfeldt, M. L., Cannon, P., and Katz, J. Rapid in vivo monitoring of chemotherapeutic response using weighted sodium magnetic resonance imaging. Clin. Cancer Res., 6: 2146-2156, 2000.
7. Evelhoch, J. L., Gillies, R. J., Karczmar, G. S., Koutcher, J. A., Maxwell, R. J., Nalcioglu, O., Raghunand, N., Ronen, S. M., Ross, B. D., and Swartz, H. M. Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia, 2: 152-165, 2000.
8. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., and Henson, P. M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol., 148: 2207-2216, 1992.
9. VerHoven, B., Schlegel, R. A., and Williamson, P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med., 182: 1597-1601, 1995.
10. Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., Rader, J. A., van Schie, R. C., LaFace, D. M., and Green, D. R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med., 182: 1545-1556, 1995.
11. Fadok, V. A., de Cathelineau, A., Daleke, D. L., Henson, P. M., and Bratton, D. L. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J. Biol. Chem., 276: 1071-1077, 2001.
12. Wiegand, U. K., Corbach, S., Prescott, A. R., Savill, J., and Spruce, B. A. The trigger to cell death determines the efficiency with which dying cells are cleared by neighbours. Cell Death Differentiation, 8: 734-746, 2001.
13. Fadok, V. A., and Henson, P. M. Apoptosis: getting rid of the bodies. Curr. Biol., 8: R693-695, 1998.
14. Blankenberg, F., Narula, J., and Strauss, H. W. In vivo detection of apoptotic cell death: a necessary measurement for evaluating therapy for myocarditis, ischemia, and heart failure. J. Nucl. Cardiol., 6: 531-539, 1999.
15. Ravanat, C., Archipoff, G., Beretz, A., Freund, G., Cazenave, J. P., and Freyssinet, J. M. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells. Biochem. J., 282: 7-13, 1992.
16. Tait, J. F., Brown, D. S., Gibson, D. F., Blankenberg, F. G., and Strauss, H. W. Development and characterization of annexin V mutants with endogenous chelation sites for (99m)Tc. Bioconj. Chem., 11: 918-925, 2000.
17. Blankenberg, F., Ohtsuki, K., and Strauss, H. W. Dying a thousand deaths. Radionuclide imaging of apoptosis. Quart. J. Nucl. Med., 43: 170-176, 1999.
18. Blankenberg, F. G., Katsikis, P. D., Tait, J. F., Davis, R. E., Naumovski, L., Ohtsuki, K., Kopiwoda, S., Abrams, M. J., Darkes, M., Robbins, R. C., Maecker, H. T., and Strauss, H. W. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl. Acad. Sci. USA, 95: 6349-6354, 1998.
19. Narula, J., Acio, E. R., Narula, N., Samuels, L. E., Fyfe, B., Wood, D., Fitzpatrick, J. M., Raghunath, P. N., Tomaszewski, J. E., Kelly, C., Steinmetz, N., Green, A., Tait, J. F., Leppo, J., Blankenberg, F. G., Jain, D., and Strauss, H. W. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat. Med., 7: 1347-1352, 2001.
20. Russell, J., O'Donoghue, J. A., Finn, R., Koziorowski, J., Ruan, S., Humm, J. L., and Ling, C. C. Iodination of annexin V for imaging apoptosis. J. Nucl. Med., 43: 671-677, 2002.
21. Yang, D. J., Azhdarinia, A., Wu, P., Yu, D. F., Tansey, W., Kalimi, S. K., Kim, E. E., and Podoloff, D. A. In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V. Cancer Biother. Radiopharm., 16: 73-83, 2001.
22. Zhao, M., Beauregard, D. A., Loizou, L., Davletov, B., and Brindle, K. M. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat. Med., 7: 1241-1244, 2001.
23. Schellenberger, E. A., Bogdanov, A., Jr., Hogemann, D., Tait, J., Weissleder, R., and Josephson, L. Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Mol. Imaging, 1: 102-107, 2002.
24. Wood, B. L., Gibson, D. F., and Tait, J. F. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood, 88: 1873-1880, 1996.
25. Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods, 184: 39-51, 1995.
26. Dumont, E. A., Reutelingsperger, C. P., Smits, J. F., Daemen, M. J., Doevendans, P. A., Wellens, H. J., and Hofstra, L. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat. Med., 7: 1352-1355, 2001.
27. Hawrysz, D., and Sevick-Muraca, E. Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. Neoplasia. 2: 388-417, 2000.
28. Ntziachristos, V., Bremer, C., Graves, E. E., and Weissleder, R. In-vivo tomographic imaging of near-infrared fluorescent probes. Mol. Imaging, 1: 82-88, 2002.
29. Ntziachristos, V., Tung, C-H., Bremer, C., and Weissleder, R. Fluorescence molecular tomography resolves protease activity in vivo. Nat. Med., 8: 757-760, 2002.
30. Browder, T., Butterfield, C., Kraling, B., Shi, B., Marshall, B., O'Reilly, M., and Folkman. J. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res., 60: 1878-1886, 2000.
31. Moore, A., Marecos, E., Simonova, M., Weissleder, R., and Bogdanov, A., Jr. Novel gliosarcoma cell line expressing green fluorescent protein: a model for quantitative assessment of angiogenesis. Microvasc. Res., 56: 145-153, 1998.
32. Bogdanov, A., Jr., Lin, C., Simonova, M., Matuszewski, L., and Weissleder, R. Cellular activation of the self-quenched fluorescent reporter probe in tumor micro-environment. Neoplasia, 4: 228-236, 2002.
33. Petrovsky, A. V., Browder, T., Weissleder, R., Mustafa, M., and Bogdanov, A., Jr. MRI monitoring of anti-angiogenic effects in drug-resistant Lewis lung carcinoma. Proceedings of 2002 Keystone Symposia: "Angiogenesis in Cancer and Other Diseases: From Genes to Function to Therapy," Banff. Alberta, Canada, February 8-13, p. 154, 2002.
34. Mahmood, U., Tung, C. H., Bogdanov, A., Jr., and Weissleder, R. Near-infrared optical imaging of protease activity for tumor detection. Radiology, 213: 866-870, 1999.
35. Blankenberg, F. G., Naumovski, L., Tait, J. F., Post, A. M., and Strauss, H. W. Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc-radiolabeled annexin V. J. Nucl. Med., 42: 309-316, 2001.
36. Ogura, Y., Krams, S. M., Martinez, O. M., Kopiwoda, S., Higgins, J. P., Esquivel, C. O., Strauss, H. W., Tait, J. F., and Blankenberg, F. G. Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation. Radiology, 214: 795-800, 2000.
37. Vriens, P. W., Blankenberg, F. G., Stoot, J. H., Ohtsuki, K., Berry, G. J., Tait, J. F., Strauss, H. W., and Robbins, R. C. The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J. Thoracic Cardiovasc. Surg., 116: 844-853, 1998.
38. Schellenberger, E. A., Bogdanov A., Jr., Petrovsky, A., Ntziachristos, N., Weissleder, R., and Josephson, L. Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. Neoplasia, in press, 2003.
39. Chishima, T., Miyagi, Y., Wang, X., Yamaoka, H., Shimada, H., Moossa, A. R., and Hoffman, R. M. Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res., 57: 2042-2047, 1997.
40. Yang, M., Baranov, E., Moossa, A. R., Penman, S., and Hoffman, R. M. Visualizing gene expression by whole-body fluorescence imaging. Proc. Natl. Acad. Sci. USA, 97: 12278-12282, 2000.
41. Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Parks, E. C., Lu, N., Selig, M., Nielson, G., Taksir, T., Jain, R. K., and Seed, B. Tumor induction of VEGF promoter activity in stromal cells. Cell, 94: 715-725, 1998.
42. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lond.), 390: 404-407, 1997.
43. Hammill, A. K., Uhr, J. W., and Scheuermann, R. H. Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp. Cell Res., 251: 16-21, 1999.
44. Ntziachristos, V., Ripoli, J., and Weissleder, R. Would near-infrared fluorescence signals propagate through large human organs for clinical studies? Opt. Lett., 27: 333-335, 2002.